Kim Sang Hun, Hong Cho Hui, Jeong Jong-Hwa, Kim Jinmi, Cho Jeong Su, Yoon Jin A, Eom Jung Seop, Lee Byeong Ju, Jang Myung Hun, Shin Myung-Jun, Shin Yong Beom
Department of Rehabilitation Medicine, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.
Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
J Korean Med Sci. 2025 May 5;40(17):e150. doi: 10.3346/jkms.2025.40.e150.
This study aimed to assess the utilization trends of pulmonary rehabilitation (PR) among lung cancer patients in Korea using the National Health Insurance Service (NHIS) database (2017 to 2021). PR was introduced and covered under the NHIS in 2016, primarily for chronic obstructive pulmonary disease, but recent evidence suggests its benefits for lung cancer patients. Data extraction was based on Korea Informative Classification of Diseases 8th revision codes C33 and C34, with PR prescriptions identified by codes MM440 and MM290. Descriptive statistical analysis was performed, and propensity score matching was used for comparison between PR and non-PR groups. Results showed a significant increase in PR utilization, with the number of patients receiving PR (MM440) rising from 1,002 in 2017 to 3,723 in 2021, indicating a 3.7-fold increase. However, the proportion of patients receiving PR remained low at 2.9% in 2021. Enhanced access to PR services and improved evaluation strategies are essential for optimizing patient outcomes.
本研究旨在利用韩国国民健康保险服务（NHIS）数据库（2017年至2021年）评估韩国肺癌患者肺康复（PR）的使用趋势。PR于2016年被引入并纳入NHIS覆盖范围，主要用于慢性阻塞性肺疾病，但最近的证据表明其对肺癌患者有益。数据提取基于韩国疾病分类第8版代码C33和C34，PR处方通过代码MM440和MM290识别。进行了描述性统计分析，并使用倾向得分匹配法对PR组和非PR组进行比较。结果显示PR的使用显著增加，接受PR（MM440）的患者人数从2017年的1002人增至2021年的3723人，增长了3.7倍。然而，2021年接受PR的患者比例仍较低，为2.9%。加强PR服务的可及性和改进评估策略对于优化患者预后至关重要。
